Form 8-K · Current report
Intuitive Surgical 8-K, filed Nov 2, 2026
- Filed
- CIK
- 0001035267
- Accession no.
- 0001035267-26-000074
Summary
Intuitive Surgical appointed Aaron Martin, President of Insurance at Humana, to its board of directors effective January 1, 2027, expanding the board from ten to eleven members. CEO Dave Rosa said Martin's payer, provider, and healthcare-technology experience would help the company expand access to minimally invasive care.
Key points
- Martin will not be appointed to any board committees as of the effective date, and the board determined he is an independent director under Nasdaq and SEC rules.
- He will receive a prorated annual cash retainer of $70,000 and an initial restricted stock unit grant valued at $93,333 that vests on the earlier of the first anniversary of the grant date or the next annual stockholder meeting.
- Martin previously spent nearly four years at Amazon as Vice President of Healthcare, where he launched Amazon Clinic, and before that was Executive Vice President and Chief Digital Officer at Providence St. Joseph Health.
- Intuitive Surgical's technologies include the da Vinci surgical system and the Ion endoluminal system.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 29, 2026, the Board of Directors (the “Board”) of Intuitive Surgical, Inc. (the “Company”) approved an increase in the size of the Board from ten to eleven members and appointed Aaron Martin to fill the resulting vacancy, effective as of January 1, 2027. Mr. Martin will not be appointed to any committees as of the effective date. The Board has determined that Mr. Martin is an independent director under applicable rules of the Nasdaq Stock Market (“Nasdaq”) and the U.S. Securities and Exchange Commission. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.